News Focus
News Focus
icon url

Neophius

03/17/20 12:19 AM

#38490 RE: daiello #38488

Absolutely this.

I'm all for drive-by sniping, but CareClix as a platform has been successfully operating for years. CareClix is a subsidiary of SOLI, and this has been proven indisputably.

SOLI has hit every single target it's laid out. Revenue and user base is growing. Deals with massive and reputable companies have been announced.

In fact, no new convertible debt has been issued beyond the beginning of the acquisition. Just solid growth with a solid team. Current debt may be paid down future profitability, but the sector does have a history of operating in the red. CareClix's model is to significantly reduce telemedicine bloat, but we need to see that reflected.

Revenue growth will be confirmed in the 10k. The beginning of the bigger growth will show up in Q1, and Q2 will confirm the massive revenue brought on by the last few PRs.

BTW, detractors have been wrong on every single ridiculous point thus far. Frankly, I was one of them early on, but SOLI has proven that the sensible position is at least neutral unless significant red flags begin appearing.
icon url

DTGoody

03/17/20 8:07 AM

#38501 RE: daiello #38488

Yes, I agree and am glad I still have my SOLI shares for the long-term. Even at .58 cents the thought of selling was not there. I still have an .008 average those remaining SOLI shares that I purchased in February 2019. I am really going to let those Ride all the way to the NASDAQ.

I absolutely know this company is legitimate, and that they are in one of the fastest growing, and hottest sectors in the world!

Have a great day everyone! I am going to go back to enjoying my vacation now! It's sunny and 81 degrees here and the ocean is calling my name!